Nextage Therapeutics (XTAE:NXTG) Total Assets : ₪1.10 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Total Assets?

Nextage Therapeutics's Total Assets for the quarter that ended in Dec. 2023 was ₪1.10 Mil.

During the past 12 months, Nextage Therapeutics's average Total Assets Growth Rate was 49.90% per year. During the past 3 years, the average Total Assets Growth Rate was -30.20% per year. During the past 5 years, the average Total Assets Growth Rate was -29.30% per year.

During the past 8 years, Nextage Therapeutics's highest 3-Year average Total Assets Growth Rate was -15.60%. The lowest was -41.30%. And the median was -35.20%.

Total Assets is connected with ROA %. Nextage Therapeutics's annualized ROA % for the quarter that ended in Dec. 2023 was -376.79%. Total Assets is also linked to Revenue through Asset Turnover. Nextage Therapeutics's Asset Turnover for the quarter that ended in Dec. 2023 was 0.82.

Nextage Therapeutics Total Assets Historical Data

The historical data trend for Nextage Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Total Assets Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

0.77

4.07

4.27

1.51

1.10

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial									4.27	4.13	1.51	0.65	1.10

Nextage Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Nextage Therapeutics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	-2.737	+	3.832
	=	1.10

Nextage Therapeutics's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	-2.737	+	3.832
	=	1.10

Nextage Therapeutics (XTAE:NXTG) Total Assets Explanation

Total Assets is connected with ROA %.

Nextage Therapeutics's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-3.28	/	( (0.646	+	1.095)	/ 2 )
	=	-3.28	/	0.8705
	=	-376.79 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Nextage Therapeutics's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.713	/	( (0.646	+	1.095)	/ 2 )
=	0.713	/	0.8705
=	0.82

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Nextage Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021